In a preliminary study we reported that soluble ICAM-1 increases by two-fold in the supernatant of tumor-activated HSE cells and that, in turn, soluble ICAM-1 increases CT26 cell secretion of VEGF [16]. The gene discussed is VEGFA; the disease is neoplasm.